8 Apr 2026
TROP2-targeted PET in triple-negative breast cancer: integrating TACSTD2 genomics and immunohistochemistry for companion diagnostic developmentPublisher siteClinical and Translational Imaging, HER2/EGFR in Cancer Research
Active, last published 2026
Mankgopo
Kgatle
Scholar“Research profile drawn from open scholarly records.”
University of Pretoria
South Africa2
H-index
12
Citations
Mankgopo has not officially claimed their profile. If you are Mankgopo, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Mankgopo Kgatle will appear here once their profile is updated.
02 · Reach
Publication output and reach
Mankgopo's work has been cited 12 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchSteve Biko Hospital, South AfricaDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
3 works16 Feb 2024Open access2cites
Barriers and enablers for implementation of digital-linked diagnostics models at point-of-care in South Africa: stakeholder engagementPublisher siteBMC Health Services Research, Data-Driven Disease Surveillance
30 Jan 2024Open access10cites
Insights into Peptidoglycan-Targeting Radiotracers for Imaging Bacterial Infections: Updates, Challenges, and Future PerspectivesPublisher siteACS Infectious Diseases, Bacteriophages and microbial interactions
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Mankgopo?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you